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ABSTRACT
Various kinds of stress on human cells induce the
formation of endogenous stress granules (SGs).
Human Argonaute 2 (hAgo2), the catalytic core
component of the RNA-induced silencing complex
(RISC), can be recruited to SGs as well as P-bodies
(PBs) indicating that the dynamic intracellular distri-
bution of hAgo2 in SGs, in PBs or at other
sub-cellular sites could be related to the efficiency
of the RNA interference (RNAi) machinery. Here,
we studied the influence of heat shock, sodium
arsenite (NaAsO2), cycloheximide (CHX) and
Lipofectamine
TM 2000-mediated transfection of
phosphorothioate (PS)-modified oligonucleotides
(ON) on the intracellular localization of hAgo2 and
the efficiency of RNAi.
Fluorescence microscopy and sedimentation
analysis of cell fractions indicate stress-induced
accumulation of hAgo2 in SGs and the loss of
distinctly composed complexes containing hAgo2
or their sub-cellular context. Transfection of cells
with PS-ON induces cell stress that is phenotypical-
ly similar to the established inducers heat shock and
NaAsO2. The intracellular re-distribution of hAgo2 is
related to its increased metabolic stability and to
decreased RNAi directed by microRNA or by short
interfering RNA. Here, we propose a functional
model of the relationship between cell stress, trans-
location of hAgo2 to SGs providing a depot function,
and loss of RNAi activity.
INTRODUCTION
The Argonaute protein family constitute a highly
conserved family of nucleic acid-binding proteins whose
members have been implicated in RNA interference
(RNAi) and related phenomena in several organisms
(1–5). In humans eight Argonaute proteins have been
identiﬁed, which can be subdivided into the Ago subfamily
and the Piwi (P-element-induced wimpy testis) subfamily
(6,7). The expression of Piwi proteins (HIWI1, HIWI2,
HIWI3 and HILI) is mostly restricted to the germ line
where they associate with piRNAs to facilitate silencing
of mobile genetic elements (6,8–10). The Ago subfamily
consists of four ubiquitously expressed members,
hAgo1-4. Despite their high sequence similarity endo-
nuclease activity is restricted to hAgo2 (5,11,12). Human
Ago2 can bind short interfering RNA (siRNA) as well as
microRNA (miRNA). As the effector molecule of the
RNA induced silencing complex (RISC) it represses
target RNA either by site-speciﬁc cleavage or by inhibition
of translation. In addition, hAgo2 seems to be involved in
distinct steps of small RNA maturation (13).
To accomplish gene regulatory processes hAgo2 needs
to interact with diverse proteins and protein complexes.
A recent study showed that most of these proteins are
RNA-binding proteins that are involved in distinct steps
of RNA processing, maturation, transport and the regu-
lation of RNA stability and translation (14). Some of
these interactions are likely to be mediated by RNA
whereas some proteins may bind directly to hAgo2 or as-
sociate with it through other protein components (14,15).
It seems to be reasonable to speculate on a dynamic
network of hAgo2-complexes, which vary in composition
and localization at distinct cellular sites of action. In
addition, miRNA components of the RNAi machinery
are thought to be involved in the control of gene expres-
sion of up to 30% of all human genes (16,17), which
regulate essential developmental processes such as
embryogenesis and cell differentiation as well as cell pro-
liferation and programmed cell death (18–20). Further,
miRNAs are thought to play an essential role in human
diseases, in particular in malignant cell proliferation (20).
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the RNAi machinery itself needs to be regulated under
certain cellular conditions by post-translational modiﬁca-
tions (21,22). For instance, a very recent study described
that phosphorylation of TRBP at four serine residues
(serine-142, -152, -283 and -286) is mediated by the
mitogen-activated protein kinase (MAPK) Erk leading
to enhanced miRNA production by increasing the stabil-
ity of the miRNA-generating complex. In addition this
post-translational modiﬁcation was shown to be import-
ant in effecting the mitogenic signalling (23). In mouse and
Drosophila it was shown that their respective Piwi proteins
underlie post-translational modiﬁcations, more precisely
arginine methylations, which have an impact on the
sub-cellular localization and stability of these proteins
(24–26).
A post-translational modiﬁcation of hAgo2 was
reported by Qi et al. (27) who described that hydroxyl-
ation of hAgo2 at proline-700 mediated by type I collagen
prolyl-4-hydroxylase [C-P4H(I)] is important for hAgo2
stability and effective siRNA-mediated RNAi. In
addition this hydroxylation had an impact on hAgo2
PB-localization. Putative hydroxylation sites were also
found in other human Ago proteins as well as in mouse
and Drosophila Ago2 proteins (21).
In line with those ﬁndings it was reported by two inde-
pendent laboratories that hAgo2-mediated gene silencing
might be linked to MAPK signalling pathways that are
activated in response to cellular stress (28,29). Zeng
et al. (29) showed that hAgo2 is post-translationally
modiﬁed by phosphorylation of serine-387 through the
p38/MAPK signalling pathway. Mutating serine-387 to
alanine decreased the localization of hAgo2 to PBs.
Adams et al. showed that the hAgo2 protein stability,
i.e. the hAgo2 expression level, is regulated by the epider-
mal growth factor receptor (EGFR)/MAPK signalling
pathway. Over-expression of EGFR increased cellular
hAgo2 protein levels, which were correlated with
enhanced miRNA activity in malignant cell growth of
breast cancer cells. MAPKs are members of signalling
pathways that transfer extracellular signals from the cell
membrane to the nucleus allowing the cell to respond to
extracellular stimuli. Thus induction of post-translational
modiﬁcations of hAgo2 and/or other proteins of the
RNAi machinery may represent mechanisms how
cellular systems regulate RNAi, thereby co-ordinating
gene expression in context of the cellular environment.
The sub-cellular localization of hAgo2 is thought to
occur mainly cytoplasmatically visualized by distinct foci
but also nuclear localization of hAgo2 has been reported
(30–32). In the cytoplasm, hAgo2 associates with two
dynamic, transient structures known as stress granules
(SGs) and processing bodies (PBs) (15,33–36). SGs are
composed of stalled pre-initiation complexes which
contain mRNA, small ribosomal subunits and a subset
of translation initiation factors including eIF3, eIF4E,
eIF4G and PABP (37,38). PBs also contain mRNA but
lack other pre-initiation factors and rather contain a
number of proteins associated with mRNA decay such
as Dcp1A and Dcp2 (37,38). SGs and PBs share some
protein components such as the cap binding protein
eIF4E and the translational repressor RAP-55, however,
not all PB components are found in SGs, or vice versa
(37). It might well be that SGs and PBs are spatially,
compositionally, or functionally linked (39).
It is consistently reported that hAgo2 associates with
components of both, SGs and PBs such as HuR for SGs
and Dcp1A for PBs (33,40). However, it is controversially
discussed whether these mRNP structures have an impli-
cation for miRNA and/or siRNA-mediated gene silencing
processes. For instance it is an ongoing matter of debate
whether PBs are required for small RNA-mediated gene
silencing or whether they simply form as a consequence of
silencing (40–43). Furthermore, hAgo2 re-localization to
PBs seems to be highly regulated by cellular signalling
pathways suggesting that recruitment of hAgo2 to PBs
may play a yet unknown function in the RNA-mediated
gene regulation (27,29). It is even less well understood why
and how hAgo2 is enriched in SGs, which can be
stimulated by oxidative and translational stress
(35,36,44). This re-localization might be dependent on
the presence of mature miRNA since no enrichment of
hAgo2 in SGs was observed in Dicer
 /  cells upon induc-
tion of translational stress by hippuristanol treatment
(35). In addition Pare et al. (36) described that the recruit-
ment of hAgo2 to both SGs and PBs is dependent on heat
shock protein (Hsp) 90 activity.
In this study we provide experimental evidence that
induction of cellular stress and accumulation of hAgo2
in SGs results in decreased siRNA- and miRNA-
mediated RNAi and we propose a model describing the
spatial and functional sub-cellular localization of hAgo2.
This model assumes that SGs represent non-functional
RNAi compartments and suggests that a dynamic and
reversible exchange of hAgo2 between SGs, PBs and
other cellular compartments may occur in human cells.
Materials and Methods
Oligonucleotides, plasmids and chemicals
All oligonucleotides were purchased from Biomers (Ulm,
Germany) or IBA (Go ¨ ttingen, Germany) HPLC puriﬁed.
PS-modiﬁed internucleotide linkages are depicted by ‘s’,
bold letters represent 20-O-methyl substitutions.
Deoxyribonucleotides are indicated by capital letters and
lower case letters indicate ribonucleotides.
siLAM Passenger 50-gccucagcacguaccucuaTT-30
Guide 50-uagagguacgugcugaggcTT-30
mlet-7A Passenger 50-acuauacaaucuacuggcguucc-30
Guide 50-ugcguuaguagguuguauaguuu-30
siAgo2 Passenger 50-gcacggaaguccaucugaauu-30
Guide 50-uucagauggacuuccgugcuu-30
Ctrl-RNA Passenger 50-cgaacucacuggucugaccTT-30
Guide 50-ggucagaccagugaguucgTT-30
asAgo2
PS 50-GsTsGsTsTsTsTsGsTsGsTsTsGsCsTsTsTsCs
AsCsTsCsTsC-30
asAgo2
OMe 50-GTGTTTTGTGTTGCTTTCACTCTC-30
asAgo2
PS/OMe 50-GsTsGsTsTsTsTsGsTsGsTsTsGsCsTsTsTsCs
AsCsTsCsTsC-30
asAgo2mut
PS 50-GsTsGsTsTsCsCsGsTsGsTsTsAsAsTsTsTsCs
AsAsGsCsTsC-30
asAgo2mut
OMe 50-GTGTTCCGTGTTAATTTCAAGCTC-30
asAgo2mut
PS/OMe 50-GsTsGsTsTsCsCsGsTsGsTsTsAsAsTsTsTsCs
AsAsGsCsTsC-30
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against nucleotide positions 3024–3047 within the open
reading frame of the hAgo2 mRNA (45). The mutated
form of this asON, termed asAgo2mut, carries point
mutations at position 6&7, 13&14 and 20&21 numbered
50 to 30.
Ctrl-ON1 50-TsAsCsCsGsCsTsCsTsTsTsTsGsAsCsTsTsTsTsA-30
Ctrl-ON2 50-GsGsTsGsTsCsAsAsCsAsGsAsAsCsTsGsGsG-30
Ctrl-ON3 50-CsTsGsAsCsTsTsGsAsTsGsGsTsCsCsAsTsG-30
Ctrl-ON4 50-GsTsGsAsCsCsTsTsCsTsGsGsAsCsCsTsTsG-30
The Renilla luciferase-encoding plasmid RL-Hmga2m7
has been described by Mayr et al. (46) and carries seven
binding sites for mlet-7A. The ﬁreﬂy luciferase-encoding
plasmid pGL3-Control was purchased from Promega
(Mannheim, Germany).
NaAsO2 and CHX were purchased from Sigma-Aldrich
(Taufkirchen, Germany). All other chemicals were
purchased from Roth (Karlsruhe, Germany) or
Sigma-Aldrich (Taufkirchen, Germany).
Cell culture and induction of cell stress
The cell line ECV-304 was described as an endothelial cell
line derived from spontaneously immortalized human
umbilical vein cells. However, the German Collection of
Microorganisms and Cell Cultures (DSMZ) showed by
DNA ﬁngerprinting that this cell line is a derivative of
the human urinary bladder carcinoma cell line T-24 (47).
ECV-304 cells were cultured in Medium 199 (Lonza,
Verviers, Belgium) supplemented with 10% fetal calf
serum (PAA, Pasching, Austria) and routinely splitted
2–3 times a week after trypsinization. Cells were incubated
at 37 C in an atmosphere of 5% CO2.
For induction of cellular stress ECV-304 cells were
treated with 250mM NaAsO2 for 90min, incubated with
20mg/ml cycloheximide for 24h, transfected with
Lipofectamine
TM 2000/100nM PS-ON (asAgo2mut
PS
unless mentioned otherwise) for 4h, or maintained over-
night at 42 C (heat shock) and 5% CO2.
For investigating the hAgo2 stability we used constitu-
tively ﬁreﬂy luciferase-expressing ECV-GL3 cells, which
were treated with CHX (20mg/ml) for up to 48h. As a
control for the translational suppression by CHX we
monitored ﬁreﬂy luciferase protein expression and
activity.
Transfection of cells
ECV-304 cells were seeded into 12-well culture plates
(Greiner, Frickenhausen, Germany) at a density of
1.5 10
5 cells/well, 16h prior to treatment with ON.
The next day, cells were washed twice with PBS. For
transfection we used Lipofectamine
TM 2000 (Invitrogen,
Karlsruhe, Germany) according to manufacturer’s in-
structions. Transfection mixes were prepared in a ﬁnal
volume of 400ml/well OptiMEM medium (Invitrogen)
containing the indicated amounts of ON and 10mg/ml of
Lipofectamine
TM 2000. Cells were incubated for 4h at
37 C and 5% CO2. Subsequently, the transfection
medium was replaced by complete medium and cells
were incubated for 20 h at 37 C and 5% CO2.
RNAi activity assay
For testing the inﬂuence of cell stress on the RNAi
activity, induction of cell stress was performed as
described above followed by the transfection of
ECV-304 cells either with 50nM mlet-7A, 100ng
RL-Hmga2m7 and 25ng pGL3-Control when testing the
miRNA-mediated gene regulation or with 50 pM siLAM
when the siRNA-mediated target suppression was
investigated. All transfections were performed in a ﬁnal
transfection volume of 400ml per well of a 12 well plate.
After 24h mlet-7A-mediated knockdown of Renilla
luciferase was measured by a dual luciferase assay
(Fermentas, Burlington, Canada). The siLAM-mediated
degradation of lamin A/C mRNA was monitored via
RT–qPCR. In order to be able to detect even small
changes of the extent of RNAi, siRNA and miRNA
concentrations were chosen such that they were in the
range of half maximal target inhibition [(48) and data
not shown].
Dual luciferase assay
The dual luciferase assay (Promega) was performed
following manufacturer’s instructions. The results were
expressed as the ratio of Renilla luciferase to ﬁreﬂy
luciferase activity (Rluc/Fluc) with ﬁreﬂy luciferase as
the transfection control. The values obtained from cells
treated with mlet-7A were normalized to those from cells
transfected with Ctrl-RNA and the same amount of
Renilla and ﬁreﬂy luciferase encoding plasmids,
respectively.
Western analysis
For quantiﬁcation of hAgo2 or ﬁreﬂy luciferase protein
levels ECV-304 and ECV-GL3 cells, respectively were
washed twice with PBS, harvested and lysed/denatured
in 30ml lysis buffer [250 mM Tris–HCl pH 6.8, 2% (w/v)
SDS, 10% (v/v) glycerine, 10mM DTT, 0.025% (w/v)
bromphenol blue] for 5min at 95 C. Samples were
separated by 8% SDS–PAGE and transferred onto
PVDF membrane (Millipore, Schwalbach, Germany).
Membranes were blocked for 30min in 1 TBST buffer
[30 mM Tris–HCl (pH 7.5), 150mM NaCl, 0.25% (v/v)
Tween-20] containing 10% (w/v) skim milk and subse-
quently incubated with the corresponding primary
antibodies overnight at 4 C. The rat anti-Ago2 (11A9)
antibody was purchased from Ascenion (Mu ¨ nchen,
Germany) and diluted 1:50 in blocking buffer. The
mouse anti-ﬁreﬂy luciferase antibody (ab7358) was
purchased from Abcam (Cambridge, UK) and diluted
1:2000 in blocking buffer. The loading control b-actin
was detected by rabbit anti-b-actin antibody (ab8227,
1:5000 dilution; Abcam). Blots were washed three times
with 1 TBST buffer and incubated with the respective
HRP-conjugated secondary antibodies [1:2000 goat
anti-rabbit IgG, 1:1000 goat anti-mouse IgG (both from
Dako, Hamburg, Germany), 1:5000 goat anti-rat IgG
from Jackson ImmunoResearch (Suffolk, UK)] for 1h at
room temperature. Then blots were washed ﬁve times with
1 TBST buffer and incubated with ECL Western
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Chemiluminescence was detected on Amersham
Hyperﬁlm
TM (GE Healthcare, Chalfont St Gilles, UK)
and quantiﬁed using Image Quant 5.2 software
(Amersham Pharmacia Biotech, Freiburg, Germany). In
case of hAgo2 the results were expressed as the ratio of
hAgo2 to b-actin signal intensities and values obtained
from ECV-304 cells treated with siAgo2 were normalized
to those obtained from cells transfected with Ctrl-RNA.
In case of ﬁreﬂy luciferase the results obtained from
ECV-GL3 cells treated with CHX were normalized to
those obtained from cells incubated in the absence of
CHX.
RT–qPCR
For the quantiﬁcation of lamin A/C mRNA, ECV-304
cells were washed twice with PBS, harvested and lysed
with 200ml PBS containing 1% (v/v) NP40. The
total RNA was extracted using phenol-chloroform
followed by ethanol precipitation. A random pool of
hexanucleotides primed the synthesis of cDNA by a
cDNA ﬁrst strand synthesis kit (Fermentas, Burlington,
Canada) according to the manufacturer’s speciﬁcations.
RT–qPCR was accomplished with Platinum SYBR
Green qPCR Supermix (Invitrogen) on the GeneAmp
5700 thermal cycler (Applied Biosystems, Freiburg,
Germany). For the detection of lamin A/C cDNA, the
following primers were used: forward primer, 50-AATG
ATCGCTTGGCGGTCTA-30; reverse primer, 50-GCCC
TGCGTTCTCCGTTT-30. The results were expressed as
the ratio of lamin A/C to b-glucoronidase cDNA with
b-glucoronidase (forward primer, 50-TTTGGAATTTTG
CCGATTTCAT-30; reverse primer, 50-GCCGAGTGAA
GATCCCCTTT-30) used as the internal control. The
values obtained from cells treated with siLAM were
normalized to those obtained from cells transfected with
Ctrl-RNA.
Fluorescence microscopy
Initially 7.5 10
4 ECV-304 cells per well were grown on a
24 well Imaging Plate FC (zell-kontakt, No ¨ rten-
Hardenberg, Germany) over night. Induction of cell
stress was performed as described above followed by
immunostaining of hAgo2, Dcp1A and TIA1 which was
performed as described recently by Ru ¨ del et al. (31). DNA
was stained with Hoechst 33342 dye (Invitrogen) at a ﬁnal
concentration of 2mg/ml for 10min at room temperature.
Microscopic analyses were carried out by semi-confocal
Apotome microscopy (Axiovert 200M) using AxioVision
software (Zeiss, Jena, Germany).
The rabbit anti-Dcp1A antibody (1:200 dilution, kindly
provided by Jens Lykke-Andersen) was used to detect
PBs. The goat anti-TIA1 antibody (1:200 dilution; Santa
Cruz Biotechnology, Heidelberg, Germany) was applied
for staining SGs. Human Ago2 was detected by the rat
anti-Ago2 (11A9) antibody purchased from Ascenion
(Mu ¨ nchen) and diluted 1:10. The respective Alexa
ﬂuorophore conjugated secondary antibodies were from
Invitrogen and used in a 1:400 dilution.
Density gradient centrifugation
A number of 3 10
6 ECV-304 cells per petri dish
(92 16mm; Sarstedt, Nu ¨ mbrecht, Germany) were
seeded 16h prior to induction of cell stress.
Subsequently cells were washed twice with PBS, harvested
and resuspended in 500ml cell fractionation buffer
(250mM sucrose, 140mM NaCl, 1mM EDTA, 20mM
Tris–HCl, pH 8.0, 2mM DTT). Cell lysis was performed
by 15 passes with a Dounce homogenizer plus 10 passes
through a 21G syringe. The nuclei of total cell extracts
were removed by centrifugation at 1000g for 10min at
4 C. The post-nuclear supernatants were layered onto a
linear gradient of 10–25% (w/v) iodixanol in cell fraction-
ation buffer and centrifuged at 48 000g for 18h at 4 C.
Gradients were eluted and the linearity of the gradients
was conﬁrmed by refractometry. Proteins were
precipitated from the gradient fractions with 20% (w/v)
trichloroacetic acid. The content of hAgo2 protein in each
fraction was determined by western analysis. In order to
determine the distribution of siRNA within gradient frac-
tions ECV-304 cells were transfected with 50nM siLAM
in a ﬁnal volume of 5ml/petri dish OptiMEM medium
(Invitrogen) containing 5mg/ml of Lipofectamine
TM 2000
prior to cell fractionation. Total RNA was isolated from
each fraction with phenol:chloroform:isoamyl alcohol
(25:24:1) followed by ethanol precipitation. The content
of siLAM in each fraction was determined via hybridiza-
tion to a
32P-labeled siLAM-speciﬁc probe according to
established methodology (49), separation of the hybridiza-
tion product on a 20% (w/v) acrylamide non-denaturing
PAGE, and quantiﬁcation in the use of a PhosphoImager
and Image Quant 5.2 software (Amersham Pharmacia
Biotech).
Statistic analysis
The ANOVA test and the program SPSS 12.0 were used to
test the signiﬁcance of differences of siRNA- or
miRNA-inducted RNAi activity (Figure 4) as well as
hAgo2 protein stability (Figure 3B) in ECV-304 cells,
which were left untreated or stressed by different means.
Results
In this study the human cell line ECV-304 was used as a
model system to investigate the relationship between
sub-cellular localization of endogenous hAgo2 and the
efﬁciency of RNAi because ECV-304 cells have been
well characterized with regard to siRNA-induced RNAi,
to microscopic analysis, and they have been analyzed by
organelle fractionation via density gradient centrifugation
(48,50).
Different kinds of cell stress direct hAgo2 to SGs
Cell stress on ECV-304 cells was induced by three different
means which included heat shock, i.e. a transient shift to
42 C. Secondly, cells were exposed transiently to NaAsO2,
an inducer of oxidative stress that has been described with
regard to re-localization of hAgo2 to SGs (27,29,35).
Thirdly, we included a widely used transfection method,
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TM 2000-based transfection of PS-ON,
which is known for being related to partial cellular toxicity
(data not shown).
Immunoﬂuorescence analyses of the localization of
endogenous hAgo2 in untreated ECV-304 cells showed
diffuse signals indicating that the majority of hAgo2
protein is distributed throughout the cytoplasm
(Figure 1A, upper panel). A clear re-localization of
hAgo2 to granular structures was observed after induction
of oxidative stress by treatment of cells with NaAsO2.
Co-staining of ECV-304 cells with antibodies against the
SG-speciﬁc marker TIA-1 conﬁrmed aggregation of
hAgo2 in SGs (Figure 1A, second upper panel). A com-
parable although less sharp localization of hAgo2 was
observed when ECV-304 cells were incubated at 42 C
prior to immunostaining (Figure 1A, second lower
panel). These observations are consistent with previous
reports as outlined in the introduction section (35,36,44).
Interestingly, transfection of ECV-304 cells with PS-ON
gave rise to a similar pattern of the intracellular localiza-
tion of hAgo2 and indicates that this kind of cell stress is
phenotypically similar to the established inducers of stress,
NaAsO2 and heat (Figure 1A, lower panel).
The hAgo2 protein is known for its localization in PBs
(27,33,34) which is partly compatible with own observa-
tions that indicate a PB-speciﬁc localization of endogen-
ous hAgo2 in untreated cells in the use of a hAgo2-speciﬁc
monoclonal antibody. In its use we and others (31)
observed that signals speciﬁc for endogenous hAgo2 are
mainly homogenously dispersed but indicate some foci,
which are positive for PB marker proteins. With regard
to this kind of localization of hAgo2 we investigated
whether cell stress has any inﬂuence on the PB association
of hAgo2. In the use of Dcp1A as an established marker
for PBs (51), we observed no detectable accumulation of
hAgo2 in PBs upon induction of cellular stress with
NaAsO2, heat, nor transfection of PS-ON (Figure 1B).
In order to shed some light on the general meaning of
these observations we investigated primary human endo-
thelial cells (HUVEC) and studied their hAgo2 localiza-
tion under cellular stress conditions. We found a similar
stress-related intracellular distribution of endogenous
hAgo2 in HUVEC cells (Supplementary Figure S1). This
is consistent with the view that the phenomena described
for ECV-304 cells are not restricted to this tumor cell line
but might rather point to a more general stress response
mechanism. It should be noted that the ratio of apparently
stressed phenotypes observed for HUVEC is somewhat
smaller than found for ECV-304 cells under same
cellular conditions, which may reﬂect a cell-type speciﬁc
extent of resistance to stress induction. In summary, we
conclude that the induction of cellular stress is related to
the accumulation of hAgo2 in SGs but not in PBs.
Human Argonaute 2 is contained in at least three
distinguishable complexes
In order to provide independent evidence for the
re-localization of hAgo2 upon cell stress we performed
cell fractionation by density gradient centrifugation. The
post-nuclear supernatant of lysates of untreated or
NaAsO2-stressed ECV-304 cells was separated on continu-
ous 10–25% (w/v) iodixanol gradients. The presence of
hAgo2 in density fractions was monitored by immuno-
blotting and visualization with rat anti-Ago2 antibody
(Figure 2A). These data indicate that in untreated
ECV-304 cells hAgo2 is present in three distinct complexes
or compartments that differ by density (Figure 2B), which
is reminiscent of a distribution of hAgo2 that was recently
described (14). Conversely, a similar analysis of the intra-
cellular distribution of hAgo2 subsequent to NaAsO2
treatment of cells shows only one major hAgo2-positive
fraction whereas complexes I and III (Figure 2B) were
absent. We cannot decide whether complex II of untreated
cells was shifted to lower density fractions (Figure 2A and
B; complex II
*) or whether this signal monitors an
independent site or structure containing hAgo2.
In order to link the gradient sedimentation data to
RNAi-related functions we performed siRNA-mediated
cleavage assays with pools of fractions representing all
of the four peaks shown in Figure 2B (complex 1:
fraction 1–3, complex 2
*: fraction 6/7, complex 2:
fraction 8/9, complex 3: fraction 12–14). Target RNA
cleavage assays were performed as described by Ho ¨ ck
et al. (14) using ICAM1-directed siRNA [si2B, (52)],
which was transfected prior to cell fractionation, and
32P-labeled in vitro transcribed cleavage substrate
[ICAM1-IVT, 140nt in length, position 53–124 represent
position 1783 – 1854 of the endogenous ICAM1-mRNA
(NM_000201.2)]. A control cleavage reaction with
cleavage competent S100 extract prepared from HeLa
cells and supplemented with iodixanol (that was used for
density gradient centrifugation) showed no inﬂuence of
iodixanol on cleavage efﬁciency (data not shown).
Subsequently we performed cleavage reactions (90min at
37 C) in which pooled fractions were tested either directly
or after immunoprecipitation with the rat anti-Ago2
(11A9) antibody (31). After anti-hAgo2 immunopre-
cipitation a weak target RNA cleavage activity was
observed in fractions representing peak II
* (fraction 6/7)
and peak II (fraction 8/9), respectively in case of untreated
cells but not in case of NaAsO2-stressed cells (data not
shown). It should be noted, however, that it was described
by Ho ¨ ck et al. (14) that only complex I is able to induce
microRNA-induced target RNA cleavage. The supposed
discrepancy between these (miRNA-mediated RNAi) and
our observations (siRNA-mediated RNAi) might be
explained by the different test systems since Ho ¨ ck et al.
used lysates of Flag/HA–hAgo2-transfected HEK 293
cells, which were separated using gradients from 15–55%
(w/v) sucrose whereas we monitored endogenous hAgo2
and used a 10–25% (w/v) iodixanol gradient for separ-
ation. Further it should be noted that for functional
tests we used target RNA cleavage by transfected
siRNA. Conversely Ho ¨ ck et al. used target RNA
cleavage mediated by endogenous miR-19b.
Furthermore we investigated a potential inﬂuence of cell
stress on the intracellular distribution of siRNA. ECV-304
cells were transfected with 50nM of lamin A/C directed
siRNA [siLAM, (53)] and then left untreated or stressed
by NaAsO2 treatment. The post-nuclear supernatant of
total cell extracts was separated on a continuous
Nucleic Acids Research,2011, Vol.39, No. 7 2731Figure 1. Different kinds of cell stress direct hAgo2 to SGs. As indicated on the left margin, ECV-304 cells were left untreated (picture 1–4 and 17–
20) or stressed by 250mM NaAsO2 for 90min at 37 C (picture 5–8 and 21–24), incubated at 42 C for 16 h (picture 9–12 and 25–28), or transfected
with Lipofectamine
TM 2000 and 100nM PS-modiﬁed ON (asAgo2mut
PS) 24 h prior to ﬁxation (picture 13–16 and 29–32). Subsequently, cells were
co-stained with a rat anti-hAgo2 antibody (red color, left column in A and B) and (A) a goat anti-TIA-1 antibody (stress granule marker, green
color) or (B) a rabbit anti-Dcp1A (P-body marker, green color). All preparations were also co-stained with Hoechst 33342 dye (blue color). Merged
images are shown on the right column. Co-staining of hAgo2 and the SG marker TIA1 can be seen in (A) whereas no co-localization could be
observed when hAgo2 and the PB-speciﬁc marker Dcp1A were co-stained. The white arrows in panel (A) indicate the staining of SGs and in panel
(B) the staining of PBs in an exemplary manner. Optical sections are displayed either as merged images or as greyscale images of the respective red,
green or blue channel. The white bar in the upper left of panel (A) and (B) represents a 10mm scale bar.
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isolated from each fraction. The siLAM content in each
fraction was determined via hybridization to a
32 P-labeled
siLAM-speciﬁc probe (Figure 2C, upper versus second
upper panel). As a further control naked siLAM was
separated in the absence of a total cell extract on a
continuous 10–25% (w/v) iodixanol gradient and its
distribution within the density gradient was determined
as described above (Figure 2C, lower panel). The compari-
son of the distribution of transfected siLAM versus naked
siLAM (Figure 2C, the two upper panels versus the lower
panel) shows a shift of a substantial amount of siRNA
from low to high density fractions. This is consistent
with the assumption that the amount of siRNA contained
in higher density fractions is complexed with cellular
material, including cellular components of the RNAi ma-
chinery. A comparison of the distribution of transfected
siRNA under normal conditions versus stress conditions
with signals normalized to the distribution of naked
siRNA indicates that the RNAi-competent fractions 6–9,
which include peak II* and II contain siRNA in either
case (Figure 2D). A closer look at the siLAM content of
fractions of untreated versus NaAsO2-treated cells indi-
cates a shoulder in fractions 8/9 of NaAsO2-treated cells.
This observation is somewhat surprising since in NaAsO2-
treated cells fraction 8 contained only 10% of the input
hAgo2 and in fraction 9 no hAgo2 signal above the detec-
tion limit could be observed (Figure 2A). Therefore we
tested other RNAi associated proteins with respect to
their sedimentation density in a 10–25% (w/v) iodixanol
Figure 2. Density gradient fractionation indicates a NaAsO2-induced re-distribution of hAgo2 to different complexes or organelles. (A and B)
ECV-304 cells were either left untreated or incubated with 250mM NaAsO2 for 90min at 37 C. The post-nuclear supernatant of total cell
extracts was separated on a continuous 10–25% (w/v) iodixanol gradient and fractions were analyzed by western analysis with rat anti-Ago2
[(A), lower panels] (B) A chart of the hAgo2 content of fractions of untreated cells shows three distinct populations (I–III) with the main peak
in fraction 8 and 9. In NaAsO2-treated cells hAgo2 is primarily located in one fraction (II*) with the main peak in fraction 6 and 7. The distribution
of hAgo2 relative to the sedimentation density is expressed as percentage of the respective signal in each fraction to the sum of all fractions. (C and
D) ECV-304 cells were transfected with 50nM siLAM and then left untreated or stressed by incubation with 250mM NaAsO2 for 90min at 37 C. (C)
Cell fractionation was performed as described above and total RNA was isolated from each fraction. The siLAM content in each fraction was
determined via hybridization to a
32P-labeled siLAM-speciﬁc probe. As a further control naked siLAM was separated in the absence of a total cell
extract on a continuous 10–25% (w/v) iodixanol gradient (lower panel). A comparison of the distribution of transfected siRNA in untretaed versus
NaAsO2-stressed cells with signals normalized to the distribution of naked siRNA is shown (D) and indicates a ‘shoulder’ in fraction 8/9 of NaAsO2-
stressed cells compared to untreated cells.
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of Dicer is not affected by the induction of cellular stress
using NaAsO2. In both cases Dicer shows a main peak in
fraction 8 (data not shown). Therefore one might specu-
late that in stressed cells siRNA still associates with the
RNAi machinery, i.e. the RISC loading complex but
cannot be handed over to hAgo2 and therefore accumu-
late in fraction 8.
In summary, we conclude that induction of cell stress
lead to altered hAgo2-containing complexes or a change
of the sub-cellular localization of hAgo2 or both, which
might also effect the cleavage activity of hAgo2 and/or the
loading of siRNA to hAgo2.
Human Argonaute 2 shows increased metabolic stability
under cell stress
Next, we investigated whether the metabolic stability of
hAgo2 is affected by cellular stress, which is indicated by
recent studies that describe a relationship between
post-translational modiﬁcations of hAgo2 induced by
cellular stress and its stability. Based on pulse-chase
experiments we and Weinmann et al. (54) estimated that
a half-life of hAgo2 in normally growing human cells of
 4 h (Supplementary Figure S6) . In this study, we did not
observe a decrease of the hAgo2 protein within 48 h after
block of translation by CHX, an inhibitor of protein
biosynthesis in eukaryotic cells. As a control for CHX
activity, i.e. the block of protein synthesis we monitored
ﬁreﬂy luciferase enzyme activity, which was clearly
decreased (Figure 3A, left versus right panel). In order
to exclude the possibility that under cellular stress condi-
tions most proteins are stabilized but protein activity may
be lost we measured the decrease of ﬁreﬂy luciferase
protein expression upon CHX treatment (Figure 3A,
middle panel). The ﬁreﬂy luciferase protein level decreased
somewhat slower than enzyme activity which we cannot
explain. However, after 24 h of CHX treatment ﬁreﬂy
luciferase was decreased on both levels. Since CHX is
known to induce translational stress this might imply a
link between cellular stress, hAgo2 metabolism and/or
its localization.
In order to test whether hAgo2 could be metabolically
stabilized or protected from catabolic decrease in SGs or
at other sites under cellular stress conditions we applied
the different kinds of cell stress and determined the level of
hAgo2 mRNA and protein upon transfection of ECV-304
cells with saturating amounts (f.c. 100nM, f.v. 400ml) of a
hAgo2-directed siRNA (Figure 3B, left and middle panel).
The levels of mRNA showed no signiﬁcant differences in
all cases. By contrast the hAgo2 protein level were signiﬁ-
cantly increased upon induction of cell stress by CHX,
NaAsO2 and PS-ON transfection. Thus, the ratio of
both hAgo2 protein and mRNA levels shows that all
different kinds of stress induction are related to an
apparent increase of hAgo2 protein (Figure 3B, right
panel). It should be noted that this phenomenon is statis-
tically signiﬁcant for CHX, NaAsO2 and PS-ON transfec-
tion while the effect on the hAgo2 protein level induced by
heat shock is only moderate.
Taken together these observations indicate that cellular
stress could be related to stabilization of hAgo2 protein.
So we asked whether increased levels of hAgo2 protein in
stressed cells are related to the extent of siRNA- or
miRNA-induced RNAi.
Translocation of hAgo2 to SGs is related to decreased
RNAi
We observed an accumulation of hAgo2 in SGs upon in-
duction of cellular stress (Figure 1) and a re-arrangement
of hAgo2-containing complexes or their re-localization or
both (Figure 2A and B). In normally growing cells we
observed hAgo2 in at least three distinguishable
complexes (complex 1, 2, 3), whereas in NaAsO2-stressed
ECV-304 cells only one major hAgo2-positive complex
(complex 2*) could be observed. Moreover we did not
detect target RNA cleavage activity in anti-hAgo2
immunoprecipitated density gradient fractions of
NaAsO2-stressed cells (data not shown) but did observe
an apparent accumulation of intracellular siRNA in
fraction 8/9 (Figure 2C and D).
The absence of complex I and III in fractionation
experiments of NaAsO2-stressed cells (Figure 2)
prompted us to ask whether the efﬁciency of small
RNA-mediated gene silencing is inﬂuenced by cellular
stress conditions. To study the effect of cellular stress on
the siRNA-mediated pathway, we used the robustly
working and potent lamin A/C-directed siRNA termed
siLAM (53). Prior to transfection of ECV-304 cells with
siRNA we induced cellular stress by treatment with
NaAsO2, heat, CHX or PS-ON. The concentration of
siLAM was chosen such that the most sensitive range of
the dose-response relationship was covered, i.e. in the
range of the IC50 concentration (48). The extent of
siRNA-induced RNAi in the lamin A/C system was
studied after 24h at the mRNA level via RT–qPCR.
It is striking that those kinds of cell stress, which were
shown to induce accumulation of hAgo2 in SGs
(compare Figure 1A) were also related to a statistically
signiﬁcant decrease in siLAM-mediated target gene
suppression (Figure 4A). In case of stress induction of
ECV-304 cells by CHX treatment we did observe an
even slightly increased siLAM-mediated suppression of
lamin A/C mRNA. This ﬁnding is difﬁcult to interpret
since CHX has been shown to resolve PBs as well as
SGs (38).
In order to investigate whether the miRNA-mediated
gene silencing pathway is similarly affected by induction
of cellular stress we used an established miRNA-regulated
system termed ‘mutated let-7A’ (mlet-7A). This miRNA is
not naturally expressed in ECV-304 cells. This allowed us
to observe the miRNA-induced phenotype despite the
background of endogenously expressed miRNAs.
Moreover it is not clear whether cell stress does or does
not inﬂuence the expression and loading of endogenous
small RNA. Therefore we decided to use transient assay
systems for both, siRNA as well as miRNA. First, cellular
stress was induced, subsequently; cells were transfected
with all components assembling the siRNA- and
miRNA-induced RNAi system, respectively. Thereby we
2734 Nucleic Acids Research, 2011,Vol.39, No. 7by-pass effects by the involvement of hAgo2 pre-loading
with endogenous miRNA because miRNA as well as
siRNA have to be newly loaded on hAgo2 after their
transfection. Thus a comparison of both systems seems
to be permitted. Moreover the transient transfection
of both systems (siRNA-mediated RNAi or miRNA-
mediated RNAi) assured constant amounts of delivered
and presumably intracellular amounts of siRNA and
miRNA, respectively. This assumption was conﬁrmed by
comparing the amounts of intracellular siLAM detectable
in stressed versus unstressed cells after transfection, which
was performed by liquid hybridization in the use of
32P-labeled siLAM-speciﬁc probe (Figure 2C).
The mlet-7A targets the Renilla luciferase mRNA,
which carries the mutated 30UTR of the high mobility
group AT-hook 2 gene (RL-Hmga2m7) with seven
binding sites for mlet-7A (46). The efﬁciency of miRNA-
induced RNAi was measured at the protein level.
A decrease of mlet-7A-mediated suppression of the
Renilla luciferase activity was observed after induction
of cellular stress in all cases (Figure 4B). While NaAsO2-
induced cell stress led to a complete loss of miRNA
function, heat shock and Lipofectamine
TM 2000/PS-ON
were related to an intermediate but statistically signiﬁcant
loss of miRNA-induced RNAi. It is important to note that
induction of translational stress by CHX treatment also
Figure 3. Translocation of hAgo2 to SGs is accompanied by its increased metabolic stability and by resistance to its siRNA-mediated knockdown.
(A) CHX treatment (20mg/ml) of ECV-GL3 cells, which blocks translation, shows suppression of stable ﬁreﬂy luciferase activity (left panel) as well as
ﬁreﬂy luciferase protein expression (middle panel) whereas hAgo2 protein was not affected for up to 48h of treatment (right panel). As control,
ECV-GL3 cells, which were cultured in the absence of CHX were used and set 1. Indicated are mean values±standard deviations. (B) ECV-304 cells
were ﬁrst stressed by different means as indicated below the bars (for details see the ‘Material and Methods’ section) and then transfected with
100nM hAgo2-directed siAgo2 in order to test whether the hAgo2 gene expression can be suppressed under cellular stress conditions. After 24 h the
gene silencing activity of siAgo2 was determined on the level of hAgo2 mRNA (RT–qPCR) and on the level of Ago2 protein (western analysis). The
results are depicted in the left (hAgo2 mRNA) and the middle (hAgo2 protein) panel. As control, Ctrl-RNA transfected ECV-304 cells were used and
set 1. The ratio of the hAgo2 protein and mRNA upon siAgo2 treatment is shown on the right panel. A value of 1 (dashed line) indicates a
comparable suppression at the mRNA and protein level whereas a value greater than 1 means that less suppression at the protein level was observed.
For each data point three to ﬁve independent experiments, each carried out in duplicates, were analyzed using the ANOVA test and the Program
SPSS 12.0. Indicated are mean values±standard error of the mean (SEM); *P<0.05, **P<0.01.
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pathway (Figure 4B). Again, the basis of this phenomenon
might not be easy to reveal because of the disassembling
effect of CHX on PBs and SGs (38), which suggests a
complex functional interference of CHX with the
miRNA-pathway at levels, which cannot be further
dissected here.
In summary, these experiments indicate a correlation
between hAgo2 aggregation in SGs and decreased
siRNA- and miRNA-induced gene silencing activity.
Avoiding the phosphorothioate chemistry of ON increases
the extent of RNAi
The Lipofectamine
TM 2000-mediated transfection of cells
with PS-modiﬁed oligonucleotides is known for being
related to a certain extent of cellular toxicity. In this
study we further showed this is related to characteristics
of cell stress with respect to sub-cellular localization and
RNAi activity of hAgo2.
The phosphorothioate chemistry was the ﬁrst kind
of chemical modiﬁcation of antisense and
immunostimulatory oligonucleotides. Still, this so-called
ﬁrst generation chemistry is widely used and it can be
found in clinical development of antisense oligonucleo-
tides. Thus, we decided to have a closer look to this
phenomenon since this is common transfection method-
ology as well as ON chemistry and the results described in
our study might generally have great impact on the use of
PS-ON.
The analysis depicted in Figure 1A shows the formation
of hAgo2-positive SGs upon Lipofectamine
TM 2000-
mediated transfection of cells with PS-ON which is
accompanied by reduced siRNA- and miRNA-mediated
RNAi (Figure 4).
To study the sequence-dependency of this phenomenon
we tested the hAgo2-directed PS-modiﬁed asON, asAgo2,
and its mutated form, asAgo2mut, in parallel to other four
fully PS-modiﬁed asONs, which do not have an endogen-
ous target. From these experiments we concluded that the
asAgo2 used in this study induces a loss of RNAi activity
by the sum of two pathways, an asON-speciﬁc suppression
of hAgo2 and a stress-related inhibition of hAgo2
(Supplementary Figure S2). The phenomenon seems to
be partly sequence-dependent since fully PS-modiﬁed
ON with different nucleotide sequences show varying
levels of reduced RNAi induced by siRNA or by
miRNA. We think that this variability could be due to
sequence motifs or to different base composition.
To study the contribution of the chemistry of ON to
stress we tested stress-related parameters in the use of the
asAgo2 and its control asAgo2mut as fully modiﬁed
PS-ON, OMe-modiﬁed PS-ON and OMe-modiﬁed ON.
As readout we ﬁrst used the ratio of hAgo2 mRNA and
protein level after transfection of asAgo2 and asAgo2mut,
respectively. This ratio indicates an increased hAgo2
protein level upon transfection with the fully
PS-modiﬁed version of asAgo2 (see also Figure 3B).
Progressively replacing the PS modiﬁcation by the OMe
chemistry avoids cell stress and allows suppression of
hAgo2 protein (Figure 5A and B). It should be noted
that OMe-modiﬁed asON did not lead to sequence-
independent decrease of RNAi (data not shown) as it
was shown for their PS-modiﬁed counterpart
(Supplementary Figure S2). Further, the mis-matched
asAgo2 version, termed asAgo2mut
OMe, did not affect
hAgo2 mRNA or protein at conditions of preserved
activity of asAgo2
OMe (data not shown). ECV-304 cells
transfected with asAgo2mut
OMe, which contains OMe
substitutions but avoids the PS-modiﬁcation did not
induce intracellular accumulation of hAgo2 in TIA1-
positive SGs (Figure 5B), i.e. large irregularly shaped
Figure 4. Translocation of hAgo2 to SGs is accompanied by decreased
siRNA- and miRNA-induced RNAi. ECV-304 cells were stressed by
different means as indicated below the bars (for detail see the ‘Material
and Methods’ section). Subsequently, (A) lamin A/C-directed siRNA
(50 pM siLAM) or (B) Renilla luciferase-directed miRNA (50nM
mlet-7A), RL-Hmga2m7 target vector and pGL3 control vector, re-
spectively were transfected. The siLAM-mediated suppression of
lamin A/C mRNA was quantiﬁed by RT–qPCR. The
mlet-7A-mediated inhibition of Renilla luciferase activity was
determined by dual-luciferase assay. The siRNA- or
miRNA-mediated gene silencing activity in the absence of cellular
stress is indicated by a dashed line in each panel. Levels greater than
the dashed line indicate loss of RNAi. As control, Ctrl-RNA trans-
fected ECV-304 cells were used and set 1. For each data point three
to ﬁve independent experiments, each carried out in duplicates, were
analyzed using the ANOVA test and the Program SPSS 12.0. Indicated
are mean values±standard error of the mean (SEM); *P<0.05,
**P<0.01.
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experiments strongly suggest that speciﬁc chemical modi-
ﬁcations of oligonuclotides, here the PS chemistry, can
interfere with the metabolism and function of hAgo2 as
a key component of the RNAi machinery. These experi-
ments also suggest to by-pass cell stress in the use of
alternatively modiﬁed oligonucleotide-based tools, e.g.
the OMe-gapmer chemistry used here.
In order to test whether the OMe-gapmer design allows
investigating functional RNAi activity in the absence of
induced cell stress we used two monitor systems
(Figure 5C and D). Firstly, siRNA-mediated suppression
of lamin A/C (53) and, secondly, the activity of the
miRNA mlet-7A in a recombinant mlet-7A-dependent
luciferase system (46). As a control for the
hAgo2-directed asON asAgo2
OMe we used the derivative
asAgo2mut
OMe that contains mis-matches at position 6/7,
13/14 and 20/21 and was shown to have no effect on
hAgo2 gene expression (data not shown). In this experi-
ment, down-regulation of hAgo2 by asAgo2
OMe leads to
the loss of siRNA-induced suppression of lamin A/C gene
expression (Figure 5C). In the mlet-7A-regulated transient
system, the asAgo2
OMe–mediated inhibition of hAgo2
shows only slight effects on the miRNA pathway
(Figure 5D). This might reﬂect a less crucial role of
hAgo2 in the miRNA pathway (45) or a bypass mechan-
ism for hAgo2 in case of its limited availability. Further
we cannot exclude that other RNAi associated proteins or
even protein networks are affected under cellular stress
conditions. This could explain different effects of the
Figure 5. Transfection of cells with Lipofectamine
TM 2000 and PS-modiﬁed ON shows stress characteristics. First, ECV-304 cells were transfected
with 100nM of hAgo2-directed asON (asAgo2) or control ON (asAgo2mut) carrying the indicated modiﬁcations. The effect of the above mentioned
pre-treatment of cells with asON on the hAgo2 expression, localization and RNAi activity was determined after 24h. (A) The ratio of hAgo2 mRNA
and hAgo2 protein indicates cell stress in case of PS-ON but not for 20-OMe-modiﬁed ON. (B) Pre-treatment of cells with 20-OMe-modiﬁed ON
(asAgo2mut
OMe) is not related to co-localization of hAgo2 (upper left panel) and TIA1 (upper right panel) in large irregularly shaped SGs. The lack
of co-localization (lower panel right) indicates the absence of stress and was interpreted as a prerequisite for the capability of a hAgo2-directed asON
to suppress hAgo2 effectively at the protein level. The white bar in the upper left panel represents a 10mm scale bar. (C and D) The effect of
asAgo2
OMe-mediated knockdown of hAgo2 on siRNA- or miRNA-induced gene silencing activity was investigated. (C) To test the siRNA pathway
ECV-304 cells were transfected with 50 pM lamin A/C directed siLAM. (D) The miRNA pathway was studied with 50nM Renilla luciferase directed
mlet-7A, RL-Hmga2m7 target vector, and pGL3 control vector, respectively. The siLAM-mediated suppression of lamin A/C mRNA was quantiﬁed
by RT–qPCR. The mlet-7A-mediated inhibition of Renilla luciferase activity was determined by dual-luciferase assay. In both cases (C and D) as
controls, Ctrl-RNA transfected ECV-304 cells were used and set 1. Indicated are mean values±standard deviations. A dashed line in each panel
indicates the full siRNA- or miRNA-mediated gene silencing activity in the absence of hAgo2 knockdown.
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gene silencing activity in the use of PS-modiﬁed versus
OMe-modiﬁed hAgo2-directed asON (Figure 5C and D;
Supplementary Figure S2).
In summary, we conclude that the OMe chemistry
rather than the PS chemistry used in transfection experi-
ments does not direct hAgo2 protein to SGs and leaves
hAgo2 accessible for RNAi machineries.
Cell stress-induced decrease of RNAi activity is reversible
Next, we investigated whether the loss of RNAi activity
could be reversible, as one would predict in a typical
stress-like scenario. The experimental design was such
that ﬁrst, cell stress was induced transiently by different
means as described in the ‘Material and Methods’ section.
Subsequently, one, two or three days after release of stress,
cells were tested for their performance in siRNA- or
miRNA-mediated RNAi by the siLAM or the mlet-7A
system as described before. Reversibility of the apparent
loss of function of hAgo2 in siRNA- and miRNA-induced
RNAi was observed in both systems. In case of siRNA-
mediated gene regulation the recovery of RNAi activity
was most pronounced for PS-ON-mediated cell stress
followed by heat shock and NaAsO2 (Figure 6). In case
of miRNA-mediated gene regulation, most obvious re-
versibility of stress-induced loss of RNAi was observed
for PS-ON-mediated stress, followed by CHX, NaAsO2
and heat shock in this order (Figure 6). These ﬁndings
are compatible with the hypothesis that the hAgo2
protein is involved in continuous spatial re-localization
between sites at which it is involved in RNAi and sites
at which it is captured and not available for active
RNAi though being physically intact. So far, we have no
data concerning the question whether this presumed
steady state involves reversible post-translational modiﬁ-
cations of hAgo2 but this should be explored in future
studies.
Discussion
This study strongly suggests that various kinds of cell
stress are related to translocation of hAgo2 protein to
SGs (Figure 1A). It is important to note that we decided
to monitor the localization of endogenous hAgo2 rather
than using transient or stable over-expression of recom-
binant and possibly tagged hAgo2 since over-expression
of proteins associated with SGs or PBs are known to
induce ‘spontaneous’ SG or PB formation even in the
absence of cellular stress (38). This kind of unintended
effect in the use of recombinant systems could partially
explain inconsistencies in the literature on the sub-cellular
localization of hAgo2, which has been described as mainly
cytoplasmatic (31,35,55) while some reports indicate an
almost exclusive association of hAgo2 with PBs (34,56).
Intracellular stress-related re-distribution of hAgo2 is
also indicated by density gradient analysis of cell fractions.
This analysis indicates at least three sub-populations of
hAgo2 in normal growing cells, which is consistent with
a recent study of Ho ¨ ck et al. (14), and only one major
hAgo2-positive population in stressed ECV-304 cells.
Target RNA cleavage assays with pools of anti-hAgo2
immuno-enriched gradient fractions were performed and
the distribution of transfected siLAM under normal con-
ditions versus stress conditions within density gradient
fractions was measured. Both analyses indicated that the
induction of cell stress also affects the cleavage activity of
hAgo2 and/or the loading of siRNA to hAgo2. This ob-
servation is compatible with suppressed RNAi in stressed
cells. It is important to note that in either case (unstressed
versus stressed cells) the RNAi-competent fractions 6–9
contain siRNA. Therefore one might hypothesize that
the observed lack of siRNA-induced RNAi in stressed
cells is not due to the absence of siRNA at critical
sub-cellular sites.
Furthermore ﬂuorescence microscopic analysis showed
no evidences that cellular stress affects neither transfection
efﬁcacy nor the sub-cellular localization of siRNA or
miRNA (Supplementary Figures S3 and S4, pictures
5–20). In this context it should be noted that the kind of
microscopic studies as performed here do not distinguish
between active and non-active siRNA or miRNA mol-
ecules. It has recently been suggested that a number of a
few hundred molecules of siRNA or less than that is ne-
cessary for half maximal target suppression (57,58). If one
considers that 10 000 molecules of siRNA or more than
that are delivered to cells after transfection it is obvious
that the intracellular localization of active species cannot
be identiﬁed in front of the background of a hundred-fold
excess of inactive species.
The inverse relationship between increased abundance
of hAgo2 after induction of cell stress and the loss of
RNAi is striking. We speculate on increased metabolic
stability of hAgo2 by its translocation to SGs or to
other sites where protein degradation is presumably
limited. This is reminiscent of a depot-like accumulation
of potentially active hAgo2 under stress conditions. We do
not speculate on increased translation of hAgo2 because
hAgo2 mRNA levels remain unaltered under cellular
stress conditions (data not shown) although we have no
experimental evidence excluding increased mRNA trans-
lation. It is important to note that microscopic studies as
performed here do not provide quantitative data on the
sub-cellular distribution of hAgo2.
Regarding the loss of miRNA- and siRNA-induced
RNAi we speculate on functional trapping of hAgo2 in
SGs. Since it was described by Kedersha et al. (38) that
SGs are transient structures which may only be present for
a limited time following the application or release of stress
we investigated the time-dependent localization of hAgo2
upon NaAsO2 treatment and conﬁrmed the above men-
tioned observation of Kedersha et al. (Supplementary
Figure S5A). From our data we estimated a half life
time of NaAsO2-induced SGs of  45min and observed
a complete re-localization of hAgo2 to a diffuse
cytoplasmatic distribution after 3 h. Surprisingly the
recovery of the RNAi activity upon removal of the
stress-inducing agent takes clearly longer (1–3 days) than
the relocalization of hAgo2 to a diffuse cytoplasmatic
localization (Figure 6C). In order to shed light on this
apparent discrepancy we investigated the siRNA-
mediated RNAi activity of hAgo2 at shorter time points
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greater phenotypes (Supplementary Figure S5B). Up to 4
h upon removal of the NaAsO2 no RNAi activity was
measurable, 6 h upon the NaAsO2 treatment a 8-fold
derepression of target gene expression in NaAsO2-
treated cells compared to untreated cells was detected,
which decreased to a 2-fold derepression after 24h
(Supplementary Figure S5B) but remained measurable
up to 3 days (Figure 6C). There are many possibilities to
speculate about reasons for the delayed RNAi recovery.
For example, one might hypothesize that hAgo2 is
converted to a modiﬁed and RNAi-incompetent version
when accumulating in SGs and that this presumed
modiﬁed hAgo2 does not re-enter the RNAi pathway
upon its release, i.e. its re-conversion to the normal state
is slow.
Based on the observations described in this study we
postulate a minimal model that relates cell stress to the
sub-cellular distribution of hAgo2 and to the efﬁciency of
RNAi (Figure 7). According to this model the cell is
sub-divided into two functionally different spaces, one
allows active RNAi because hAgo2 is present in a
biologically active form and the second does not allow
functional RNAi because hAgo2 is present in a non-active
state. The functionally active space includes PBs as well as
nuclear and cytosolic portions. Conversely, we assign SGs
to the functionally inactive space. Further we postulate a
dynamic exchange of hAgo2 between both compartments.
Upon the induction of cell stress by NaAsO2, PS-ON or
heat shock major amounts of hAgo2 are translocated
from functionally active sites to inactive sites, which
include SGs. Even though ﬂuorescence microscopy does
not provide quantitative data their ﬂuorescence intensity
at cellular stress conditions is remarkably high. Thus, one
might speculate that this is the major compartment of
inactive hAgo2. After release of stress, however, the
system seems to act in a reversible manner because
hAgo2 is redistributed to the non-stressed state
(Supplementary Figure S5A) and RNAi is restored
(Supplementary Figure S5B and Figure 6).
In this context it should be noted that recently Kedersha
et al. (39) proposed that mRNA released from
Figure 6. Cell stress-induced decrease of RNAi activity is reversible. Cell stress was transiently induced by the means indicated in the top of each
panel [(A)–(D), for detail see the ‘Material and Methods’ section]. One, 2 or 3 days after release of stress, ECV-304 cells were tested for their
capability to perform siRNA- or miRNA-mediated RNAi. Brieﬂy, ECV-304 cells were transfected either with 50 pM lamin A/C directed siLAM or
with 50nM Renilla luciferase directed mlet-7A, RL-Hmga2m7 target vector and pGL3 control vector at day 1–3 after induction of cell stress. The
extent of siRNA- and miRNA-mediated target inhibition in the absence of cell stress was normalized to Ctrl-RNA transfected ECV-304 cells and set
to 1 (indicated by a dashed line in each panel). Higher numbers indicate derepression of target expression, i.e. loss of efﬁcacy of siRNA or miRNA,
respectively. Indicated are mean values±standard deviations.
Nucleic Acids Research,2011, Vol.39, No. 7 2739disassembled polysomes is sorted and remodeled at SGs,
from which selected transcripts are than delivered to PBs
for degradation. Similarly, Leung et al. (35,59) proposed
that the localization of miRNPs to PBs and SGs reﬂects
different functional states of miRNPs. Further studies
should focus on the complex interplay between stress,
RNAi mechanism and cellular signaling pathways.
One might further speculate that hAgo2 provides im-
portant cellular functions that require its localization in
SGs, which is adverse to the cellular capability of RNAi.
This opposing situation might occur without any causa-
tive relationship between cell stress and typical known
RNAi-based processes. It might occur coincidently,
which would be consistent with the ﬁndings of Kedersha
et al. (39). Alternatively, one might speculate that the
cellular capability of active RNAi could be in conﬂict
with crucial stress response mechanisms, i.e. an inverse
coupling of both cellular response options might exist.
This would imply that the cellular response to a severe
stress situation has higher priority than executing RNAi
including miRNA-facilitated regulation of gene
expression.
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